Myrbetriq

Product manufactured by Remedyrepack Inc.

Application Nr Approved Date Route Status External Links
NDA202611 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Myrbetriq Is A Beta-3 Adrenergic Agonist Indicated For The Treatment Of Overactive Bladder (Oab) With Symptoms Of Urge Urinary Incontinence, Urgency, And Urinary Frequency ( 1.1 ). Myrbetriq, In Combination With The Muscarinic Antagonist Solifenacin Succinate, Is Indicated For The Treatment Of Oab With Symptoms Of Urge Urinary Incontinence, Urgency, And Urinary Frequency ( 1.2 ). 1.1 Monotherapy Myrbetriq ® Is A Beta-3 Adrenergic Agonist Indicated For The Treatment Of Overactive Bladder (Oab) With Symptoms Of Urge Urinary Incontinence, Urgency, And Urinary Frequency. 1.2 Combination With Muscarinic Antagonist Myrbetriq In Combination With The Muscarinic Antagonist Solifenacin Succinate Is Indicated For The Treatment Of Oab With Symptoms Of Urge Urinary Incontinence, Urgency, And Urinary Frequency.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mirabegron MIRABEGRON ZINC1996784

Comments